Literature DB >> 11279196

A novel p75TNF receptor isoform mediating NFkappa B activation.

C Seitz1, P Muller, R C Krieg, D N Mannel, T Hehlgans.   

Abstract

We report the identification of a novel p75TNF receptor isoform termed icp75TNFR, which is generated by the use of an alternative transcriptional start site within the p75TNFR gene and characterized by regulated intracellular expression. The icp75TNFR protein has an apparent molecular mass of approximately 50 kDa and is recognized by antibodies generated against the transmembrane form of p75TNFR. The icp75TNFR binds the tumor necrosis factor(TNF) and mediates intracellular signaling. Overexpression of the icp75TNFR cDNA results in TNF-induced activation of NFkappaB in a TNF receptor-associated factor 2 (TRAF2)-dependent manner. Thus, our results provide an example for intracellular cytokine receptor activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11279196     DOI: 10.1074/jbc.M101336200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games.

Authors:  Thomas Hehlgans; Klaus Pfeffer
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

2.  Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo.

Authors:  Dietrich B Conze; Lori Albert; David A Ferrick; David V Goeddel; Wen-Chen Yeh; Tak Mak; Jonathan D Ashwell
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

3.  Tumor necrosis factor receptor 2 promotes growth of colorectal cancer via the PI3K/AKT signaling pathway.

Authors:  Tao Zhao; Huihui Li; Zifeng Liu
Journal:  Oncol Lett       Date:  2016-11-21       Impact factor: 2.967

Review 4.  Steroid-refractory severe ulcerative colitis: what are the available treatment options?

Authors:  Alan C Moss; Mark A Peppercorn
Journal:  Drugs       Date:  2008       Impact factor: 9.546

5.  FOXO3a regulates oxygen-responsive expression of tumor necrosis factor receptor 2 in human dermal microvascular endothelial cells.

Authors:  Bo Ding; Nancy C Kirkiles-Smith; Jordan S Pober
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

Review 6.  Alternative splicing in the NF-kappaB signaling pathway.

Authors:  Joshua R Leeman; Thomas D Gilmore
Journal:  Gene       Date:  2008-07-22       Impact factor: 3.688

7.  Colocalization of endogenous TNF with a functional intracellular splice form of human TNF receptor type 2.

Authors:  Christoph Scherübl; Wulf Schneider-Brachert; Stephan Schütze; Thomas Hehlgans; Daniela N Männel
Journal:  J Inflamm (Lond)       Date:  2005-07-04       Impact factor: 4.981

8.  TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS.

Authors:  Cécile Rittore; Déborah Méchin; Elodie Sanchez; Léa Marinèche; Vuthy Ea; Stephan Soler; Marion Vereecke; Aude Mallavialle; Eric Richard; Isabelle Duroux-Richard; Florence Apparailly; Isabelle Touitou; Sylvie Grandemange
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

9.  Alternative splicing regulation in tumor necrosis factor-mediated inflammation.

Authors:  Eduardo López-Urrutia; Alma Campos-Parra; Luis Alonso Herrera; Carlos Pérez-Plasencia
Journal:  Oncol Lett       Date:  2017-09-06       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.